Teva Pharmaceutical Industries and Intel announced on Thursday a wearable partnership focused on Huntington’s disease patients.
Huntington’s disease, which affects approximately 30,000 Americans, is an inherited condition that damages nerve cells in the brain. This causes a breakdown in motor skills, cognition, and behavior